Disease · fungal

Giant corn ergot

Claviceps gigantea

Description

Claviceps gigantea is a specialized fungal pathogen that causes the disease known as giant corn ergot. Belonging to the Ascomycota phylum, this fungus is characterized by the formation of unusually large sclerotia on the ears of maize plants. It represents a significant phytopathological concern in specific regions, particularly in high-altitude areas where environmental conditions favor its life cycle.

The primary host for this pathogen is maize (Zea mays). The disease is most prevalent in areas with high humidity and moderate temperatures during the silking stage of the plant. Unlike the common ergot of rye, this species is highly adapted to corn and targets the developing kernels within the ear, effectively replacing healthy grain with fungal structures.

The clinical signs of the disease are unmistakable: the development of massive, dark-colored, hard sclerotia protruding from the ear. These fungal growths can significantly distort the shape of the cob and prevent normal kernel development. Because of their size and color, these sclerotia are easily detected during the maturation phase of the corn crop.

The development of the disease is strictly dependent on the presence of inoculum and favorable weather conditions during flowering. Wind and insects facilitate the transfer of ascospores to the corn silks. Once the spore lands on the silk, it germinates and colonizes the ovary. Extended periods of cool, wet weather during pollination are the primary drivers of localized epidemics.

The economic impact of Claviceps gigantea is substantial, not only due to direct yield losses but also because of the toxicity of the sclerotia. They contain ergot alkaloids that are hazardous to livestock if ingested. Management strategies focus on preventive agronomic practices, such as deep tillage to bury sclerotia, the use of resistant corn hybrids, and ensuring optimal crop rotation to break the cycle of the pathogen.

Marketplace

Products · 0

Community

Discussion

No discussions yet — be the first.